| 000 | 01176 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517132932.0 | ||
| 264 | 0 | _c20170427 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a1538-8689 | ||
| 024 | 7 |
_a10.1097/01.NURSE.0000511806.60464.a4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHussar, Daniel A | |
| 245 | 0 | 0 |
_aNew Drugs 2017, part 1. _h[electronic resource] |
| 260 |
_bNursing _cFeb 2017 |
||
| 300 |
_a32-39 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 |
_aDrug Therapy _xnursing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin, Long-Acting _xtherapeutic use |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 |
_aPiperidines _xtherapeutic use |
| 650 | 0 | 4 |
_aPolymers _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrrolidinones _xtherapeutic use |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 650 | 0 | 4 |
_aUrea _xanalogs & derivatives |
| 773 | 0 |
_tNursing _gvol. 47 _gno. 2 _gp. 32-39 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.NURSE.0000511806.60464.a4 _zAvailable from publisher's website |
| 999 |
_c26759440 _d26759440 |
||